{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:47:42Z","timestamp":1783579662912,"version":"3.55.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","license":[{"start":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T00:00:00Z","timestamp":1732147200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>This study aimed to assess the usefulness of thyroglobulin (Tg) after radioiodine (RAI) therapy in predicting excellent response (ER) to therapy in postoperative differentiated thyroid cancer (DTC).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective observational study was conducted on postoperative DTC patients who underwent RAI from August 2018 to December 2022. Various factors were analyzed to predict ER to treatment. This involved Tg under stimulation (sTg) before RAI, Tg immediately (imTg) 112\u2005h post-RAI and imTg\/sTg(rTg). Based on the efficacy of RAI, patients were categorized into two groups: ER and non-ER (NER). Univariate logistic analysis was utilized to compare parameters between the two groups, followed by binary logistic regression analysis on factors associated with ER. Receiver operating characteristic (ROC) curves were employed to evaluate the sensitivity, specificity, and optimal diagnostic cutoff points for parameters affecting ER.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>The analysis included 45 ER patients and 56 NER patients. Statistical significance was found in the binary logistic regression analysis for the number of lymph nodes in the lateral cervical region (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.016), sTg (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.021), and rTg (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\u2264\u20050.001) concerning ER. ROC curve analysis revealed that the rTg area under the curve was 0.845, with an optimal cutoff value of 11.78, sensitivity of 82.6%, and specificity of 74.5%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Post-RAI therapy, significant value is demonstrated by rTg with high sensitivity and specificity. This provides a foundation for the evaluation and decisions about DTC treatment in advance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mnm.0000000000001933","type":"journal-article","created":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T08:00:08Z","timestamp":1732176008000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Predictive value of thyroglobulin after radioiodine therapy for excellent response to treatment in postoperative thyroid cancer"],"prefix":"10.1097","author":[{"given":"Yuan","family":"Zhu","sequence":"first","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoying","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Radiology, The Affiliated Hospital of Xuzhou medical University, Xuzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Liu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinghua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiancun","family":"Hou","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhu","sequence":"additional","affiliation":[{"name":"Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,21]]},"reference":[{"key":"R1-20241122","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1097-0142(20000701)89:1<202::AID-CNCR27>3.0.CO;2-A","article-title":"Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the United States during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study.","volume":"89","author":"Hundahl","year":"2000","journal-title":"Cancer"},{"key":"R2-20241122","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1210\/er.2015-1090","article-title":"Thyroglobulin from molecular and cellular biology to clinical endocrinology.","volume":"37","author":"Di Jeso","year":"2016","journal-title":"Endocr Rev"},{"key":"R3-20241122","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cca.2007.11.002","article-title":"Thyroglobulin and human thyroid cancer.","volume":"388","author":"Lin","year":"2008","journal-title":"Clin Chim Acta"},{"key":"R4-20241122","first-page":"433","article-title":"Prediction of malignancy in the solitary thyroid nodule by physical examination, thyroid scan, fine-needle biopsy and serum thyroglobulin. A prospective study of 100 surgically treated patients.","volume":"150","author":"Christensen","year":"1984","journal-title":"Acta Chir Scand"},{"key":"R5-20241122","doi-asserted-by":"crossref","first-page":"111227","DOI":"10.1016\/j.mce.2021.111227","article-title":"Structure and genetic variants of thyroglobulin: pathophysiological implications.","volume":"528","author":"Citterio","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"R6-20241122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer.","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"R7-20241122","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","article-title":"Controversies, consensus, and collaboration in the use of (131)I therapy in differentiated thyroid cancer: a joint statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association.","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"R8-20241122","doi-asserted-by":"crossref","first-page":"1015798","DOI":"10.3389\/fendo.2022.1015798","article-title":"Analysis of factors influencing the clinical outcome after surgery and (131)I therapy in patients with moderate-risk thyroid papillary carcinoma.","volume":"13","author":"Li","year":"2022","journal-title":"Front Endocrinol"},{"key":"R9-20241122","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MNM.0000000000001554","article-title":"Analysis of correlation factors influencing the outcome of initial 131I remnant ablative therapy in intermediate- to high-risk patients with papillary thyroid microcarcinoma.","volume":"43","author":"Wu","year":"2022","journal-title":"Nucl Med Commun"},{"key":"R10-20241122","first-page":"439","article-title":"The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: a retrospective cohort study and systematic review of the literature.","volume":"14","author":"Karvounis","year":"2020","journal-title":"Oncol Rev"},{"key":"R11-20241122","first-page":"1362","article-title":"Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.","volume":"38","author":"Muratet","year":"1997","journal-title":"J Nucl Med"},{"key":"R12-20241122","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s12149-018-1313-5","article-title":"An enhanced treatment effect can be expected from a higher serum thyroglobulin level after radioactive iodine therapy.","volume":"33","author":"Choi","year":"2019","journal-title":"Ann Nucl Med"},{"key":"R13-20241122","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12149-014-0927-5","article-title":"Serum thyroglobulin level after radioiodine therapy (day 3) to predict successful ablation of thyroid remnant in postoperative thyroid cancer.","volume":"29","author":"Kim","year":"2015","journal-title":"Ann Nucl Med"},{"key":"R14-20241122","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1007\/s00259-005-1866-0","article-title":"Prognostic value of an increase in the serum thyroglobulin level at the time of the first ablative radioiodine treatment in patients with differentiated thyroid cancer.","volume":"32","author":"Bernier","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R15-20241122","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s10495-015-1116-2","article-title":"Effect of combined radiation injury on cell death and inflammation in skin.","volume":"20","author":"Jadhav","year":"2015","journal-title":"Apoptosis"},{"key":"R16-20241122","first-page":"1121","article-title":"Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.","volume":"83","author":"Spencer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R17-20241122","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/RLU.0b013e31824852f8","article-title":"Preablation stimulated thyroglobulin is a good predictor of successful ablation in patients with differentiated thyroid cancer.","volume":"37","author":"Kendler","year":"2012","journal-title":"Clin Nucl Med"},{"key":"R18-20241122","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MNM.0b013e328341c802","article-title":"Serum thyroglobulin predicts thyroid remnant ablation failure with 30 mCi iodine-131 treatment in patients with papillary thyroid carcinoma.","volume":"32","author":"Tamilia","year":"2011","journal-title":"Nucl Med Commun"},{"key":"R19-20241122","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/BF03343973","article-title":"Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.","volume":"25","author":"Lima","year":"2002","journal-title":"J Endocrinol Invest"},{"key":"R20-20241122","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/09553009314552091","article-title":"Membranes as sensitive targets in thymocyte apoptosis.","volume":"63","author":"Ramakrishnan","year":"1993","journal-title":"Int J Radiat Biol"},{"key":"R21-20241122","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0360-3016(96)00480-4","article-title":"Acute radiation thyroiditis.","volume":"36","author":"Nishiyama","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-20241122","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1590\/2359-3997000000103","article-title":"Insights into the posttranslational structural heterogeneity of thyroglobulin and its role in the development, diagnosis, and management of benign and malignant thyroid diseases.","volume":"60","author":"Xavier","year":"2016","journal-title":"Arch Endocrinol Metab"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001933","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T11:00:54Z","timestamp":1732273254000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000001933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,21]]},"references-count":22,"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000001933","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"value":"0143-3636","type":"print"},{"value":"1473-5628","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,21]]}}}